{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:39:50Z","timestamp":1768487990615,"version":"3.49.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pathol.2022.12.350","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T15:21:14Z","timestamp":1674141674000},"page":"287-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["An update on genetic aberrations in T-cell neoplasms"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-8060","authenticated-orcid":false,"given":"Megan","family":"Parilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres E.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-3633","authenticated-orcid":false,"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2022.12.350_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Hematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib2","article-title":"Aggressive mediastinal lymphomas","author":"Wang","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2020.00273","article-title":"The physiopathology of T-cell acute lymphoblastic leukemia: focus on molecular aspects","volume":"10","author":"Fattizzo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib5","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/biomedicines9111621","article-title":"T-cell acute lymphoblastic leukemia\u2014current concepts in molecular biology and management","volume":"9","author":"Shiraz","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.pathol.2022.12.350_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2022.12.350_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/leu.2013.158","article-title":"Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia","volume":"28","author":"Patel","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exphem.2017.06.001","article-title":"TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia","volume":"53","author":"Sanda","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib10","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2022.12.350_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.12.350_bib12","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2019.00127","article-title":"Opportunities to target the life cycle of Epstein-Barr virus (EBV) in EBV-associated lymphoproliferative disorders","volume":"9","author":"Dugan","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib15","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pathol.2022.12.350_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00238-19","article-title":"Mechanisms of B-cell oncogenesis induced by Epstein-Barr virus","volume":"93","author":"Saha","year":"2019","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2022.12.350_bib17","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/emm.2014.105","article-title":"Epstein\u2013Barr virus-positive T\/NK-cell lymphoproliferative disorders","volume":"47","author":"Cai","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pathol.2022.12.350_bib18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib19","first-page":"5738","article-title":"The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder","volume":"7","author":"Smith","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib20","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein\u2013Barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2022.12.350_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic lymphohistiocytosis and Epstein\u2013Barr virus: a complex relationship with diverse origins, expression and outcomes","volume":"196","author":"El-Mallawany","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib22","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1128\/JVI.78.8.4108-4119.2004","article-title":"Role of NF-\u03baB in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells","volume":"78","author":"Cahir-McFarland","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2022.12.350_bib23","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","article-title":"NF-\u03baB is essential for the progression of KSHV-and EBV-infected lymphomas in\u00a0vivo","volume":"107","author":"Keller","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2022.12.350_bib25","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/1097-0142(19901215)66:12<2557::AID-CNCR2820661218>3.0.CO;2-2","article-title":"Epstein\u2013Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype","volume":"66","author":"Su","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2022.12.350_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2141.1995.tb03379.x","article-title":"Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis","volume":"90","author":"Kaneko","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib27","first-page":"572","article-title":"Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome","volume":"82","author":"Chen","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428190009058510","article-title":"Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases","volume":"37","author":"Imashuku","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2022.12.350_bib29","first-page":"263","article-title":"Fatal Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with clonal karyotype abnormality","volume":"71","author":"Ito","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-4608(01)00435-6","article-title":"Oligoclonal expansion of \u03b1\u03b2 T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with abnormal karyotypes","volume":"129","author":"Ishii","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2022.12.350_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1703806","article-title":"Post-transplant lymphoproliferative disorder: a review","volume":"31","author":"Loren","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pathol.2022.12.350_bib32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein\u2013Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2022.12.350_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein\u2013Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.pathol.2022.12.350_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/aol-20-34","article-title":"Narrative review of chronic active EBV infection\u2014advances in clinical management","volume":"5","author":"Sawada","year":"2021","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.pathol.2022.12.350_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-981-10-7230-7_21","article-title":"EBV in T-\/NK-cell tumorigenesis","volume":"1045","author":"Kimura","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pathol.2022.12.350_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","article-title":"How I diagnose EBV-positive B- and T-cell lymphoproliferative disorders","volume":"159","author":"Dojcinov","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib37","doi-asserted-by":"crossref","first-page":"e2328","DOI":"10.1002\/rmv.2328","article-title":"EBV associated T-and NK-cell lymphoproliferative diseases: a comprehensive overview of clinical manifestations and novel therapeutic insights","volume":"32","author":"Shafiee","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.pathol.2022.12.350_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","article-title":"Epstein\u2013Barr virus-associated T-and NK-cell lymphoproliferative diseases: an update and diagnostic approach","volume":"52","author":"Hue","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2022.12.350_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fped.2018.00417","article-title":"Overview of EBV-associated T\/NK-cell lymphoproliferative diseases","volume":"6","author":"Kimura","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2022.12.350_bib41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/pathogens10081057","article-title":"A\u00a0systematic review of Epstein\u2013Barr virus latent membrane protein 1 (LMP1) gene variants in nasopharyngeal carcinoma","volume":"10","author":"Banko","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.pathol.2022.12.350_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2022.12.350_bib43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib44","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/ijms19071931","article-title":"The genomics and molecular biology of natural killer\/T-cell lymphoma: opportunities for translation","volume":"19","author":"De Mel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2022.12.350_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.2015.139253","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma","volume":"101","author":"Yoo","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2012.09.028","article-title":"HTLV-1: persistence and pathogenesis","volume":"435","author":"Cook","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.pathol.2022.12.350_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-030-57362-1_10","article-title":"HTLV-1 replication and adult T cell leukemia development","volume":"217","author":"Giam","year":"2021","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.pathol.2022.12.350_bib49","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-\u03baB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.pathol.2022.12.350_bib50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pathogens9070543","article-title":"Mechanisms of oncogenesis by HTLV-1 tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.pathol.2022.12.350_bib51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng.3808","article-title":"Disruption of the ATXN1\u2013CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans","volume":"49","author":"Lu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib54","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fonc.2020.00152","article-title":"Insights into genetic landscape of large granular lymphocyte leukemia","volume":"10","author":"Teramo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.775363","article-title":"Advanced pathogenetic concepts in T-Cell prolymphocytic leukemia and their translational impact","volume":"11","author":"Braun","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/gcc.1141","article-title":"A\u00a0complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia","volume":"31","author":"Soulier","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2022.12.350_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.22313","article-title":"Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker","volume":"55","author":"Stengel","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2022.12.350_bib60","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.13952","article-title":"Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia","volume":"173","author":"L\u00f3pez","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib62","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/gcc.22141","article-title":"Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia","volume":"53","author":"Bergmann","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2022.12.350_bib64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11912-021-01159-y","article-title":"Large granular lymphocytic leukemia: current state of diagnosis, pathogenesis and treatment","volume":"24","author":"Magnano","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pathol.2022.12.350_bib65","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib66","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2022.12.350_bib67","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/leu.2012.350","article-title":"STAT3 mutations are highly specific for large granular lymphocytic leukemia","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib68","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib69","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","article-title":"High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia","volume":"128","author":"Andersson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib70","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fonc.2020.00152","article-title":"Insights into genetic landscape of large granular lymphocyte leukemia","volume":"10","author":"Teramo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib71","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/leu.2017.49","article-title":"Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach","volume":"31","author":"Coppe","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib72","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2022.12.350_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.pathol.2022.12.350_bib74","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11899-021-00634-4","article-title":"Enteropathy-associated T cell lymphoma","volume":"16","author":"Al Somali","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.pathol.2022.12.350_bib75","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","article-title":"Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II","volume":"45","author":"Soderquist","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib76","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00428-005-1214-6","article-title":"Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma","volume":"446","author":"Cejkova","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2022.12.350_bib78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41379-021-00937-0","article-title":"Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up","volume":"35","author":"Vega","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib79","series-title":"Hematopathology","year":"2017"},{"key":"10.1016\/j.pathol.2022.12.350_bib80","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/cancers14102483","article-title":"Cellular origins and pathogenesis of gastrointestinal NK- and T-cell lymphoproliferative disorders","volume":"14","author":"Hue","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2022.12.350_bib81","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/cancers12123539","article-title":"Monomorphic epitheliotropic intestinal t-cell lymphoma in asia frequently shows setd2 alterations","volume":"12","author":"Tomita","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.pathol.2022.12.350_bib82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/his.14289","article-title":"Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications","volume":"78","author":"Foukas","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2022.12.350_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2022.12.350_bib84","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairism\u00e4gi","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib85","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib86","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/cancers13081931","article-title":"Mycosis fungoides and S\u00e9zary syndrome: an integrative review of the pathophysiology, molecular drivers, and targeted therapy","volume":"13","author":"Garc\u00eda-D\u00edaz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.pathol.2022.12.350_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib88","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib89","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fonc.2020.00514","article-title":"New insights into the complex mutational landscape of Sezary syndrome","volume":"10","author":"Mirza","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib90","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.semdp.2016.11.002","article-title":"A\u00a0new molecular paradigm in mycosis fungoides and Sezary syndrome","volume":"34","author":"Elenitoba-Johnson","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","article-title":"Mycosis fungoides and S\u00e9zary syndrome: an update","volume":"33","author":"Larocca","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.pathol.2022.12.350_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK\u2013STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2022.12.350_bib94","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3389\/fonc.2019.01558","article-title":"An update on molecular biology of cutaneous T cell lymphoma","volume":"9","author":"Walia","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib96","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.3880577","article-title":"Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma","volume":"15","author":"\u015een","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib97","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2022.12.350_bib98","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib99","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hon.2850","article-title":"Cutaneous T-cell lymphomas\u2014an update 2021","volume":"39","author":"Kempf","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib100","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/bloodadvances.2021004562","article-title":"Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations","volume":"5","author":"Koh","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2022.12.350_bib101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11899-020-00583-4","article-title":"Primary cutaneous CD30+ lymphoproliferative disorders: a comprehensive review","volume":"15","author":"Di Raimondo","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.pathol.2022.12.350_bib102","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.mpdhp.2018.06.005","article-title":"Update on cutaneous lymphomas","volume":"24","author":"Ortonne","year":"2018","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib104","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A\u00a0novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2022.12.350_bib106","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12185-015-1895-9","article-title":"Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma","volume":"103","author":"Kato","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5021\/ad.2018.30.2.255","article-title":"A\u00a0case of primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma","volume":"30","author":"Moon","year":"2018","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.pathol.2022.12.350_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib109","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic \u03b3\u03b4 T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2022.12.350_bib111","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib112","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib113","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.2019004498","article-title":"Increased prevalence of BRCA1\/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast","volume":"136","author":"De Boer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib114","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Bombery","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/CCO.0000000000000476","article-title":"New insights into breast implant-associated anaplastic large cell lymphoma","volume":"30","author":"Laurent","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.pathol.2022.12.350_bib116","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma","volume":"473","author":"Letourneau","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2022.12.350_bib117","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tbj.14205","article-title":"Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway","volume":"27","author":"Quesada","year":"2021","journal-title":"Breast J"},{"key":"10.1016\/j.pathol.2022.12.350_bib119","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood.2020005372","article-title":"Chromosome 20 loss is characteristic of breast implant\u2013associated anaplastic large cell lymphoma","volume":"136","author":"Los-de Vries","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib121","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cancers14071650","article-title":"Anaplastic large cell lymphoma: molecular pathogenesis and treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.pathol.2022.12.350_bib122","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2016-05-717793","article-title":"Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target","volume":"129","author":"Werner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib123","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2018.213512","article-title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","volume":"104","author":"Sibon","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib124","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib125","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The heterogeneous landscape of ALK negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2022.12.350_bib126","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib127","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t (6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib128","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","author":"Qiu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib129","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2022.12.350_bib132","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib133","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib134","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.12.350_bib136","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib138","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib139","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A\u00a0recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.12.350_bib140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.exphem.2016.09.002","article-title":"Variegated RHOA mutations in human cancers","volume":"44","author":"Kataoka","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pathol.2022.12.350_bib141","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41467-021-24037-4","article-title":"FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T cell lymphoma, not otherwise specified","volume":"12","author":"Debackere","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2022.12.350_bib142","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.2019002401","article-title":"FER and FES tyrosine kinase fusions in follicular T-cell lymphoma","volume":"135","author":"Debackere","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib143","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11899-018-0460-z","article-title":"Molecular insights into pathogenesis of peripheral T cell lymphoma: a review","volume":"13","author":"Lone","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.pathol.2022.12.350_bib144","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2017-11-764357","article-title":"Novel insights into the pathogenesis of T-cell lymphomas","volume":"131","author":"Van Arnam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib145","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib146","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.2019003385","article-title":"Subclassifying peripheral T-cell lymphoma NOS","volume":"134","author":"Carbone","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib147","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma\u2013NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.12.350_bib148","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2020.05.006","article-title":"A\u00a0suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes","volume":"102","author":"Vega","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2022.12.350_bib149","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.12.350_bib150","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2020.262659","article-title":"CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)","volume":"106","author":"Maura","year":"2021","journal-title":"Haematologica"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:30:09Z","timestamp":1758472209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0031302523000272"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2022.12.350","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on genetic aberrations in T-cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2022.12.350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}